Northland initiated coverage of Connect Biopharma (CNTB) with an Outperform rating and $7.50 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTB:
- Connect Biopharma Ends ADS Agreement with Deutsche Bank
- Connect Biopharma plans to terminate ADR program, list shares on Nasdaq
- Connect Biopharma Regains Nasdaq Compliance
- Connect Biopharma regains Nasdaq compliance
- Connect Biopharma Holdings: A Promising Investment with Strategic Drug Developments and Strong Financial Position